Epigenome-wide association study
An epigenome-wide association study (EWAS) is a hypothesis-free, genome-scale method that systematically tests whether epigenetic marks — predominantly CpG-site DNA methylation — differ between individuals with and without a trait, disease, or exposure. By scanning hundreds of thousands of genomic positions simultaneously, EWAS identifies loci where the epigenome is reproducibly associated with a phenotype, offering a layer of biological regulation that classical GWAS does not capture.
Zdrojový záznam
Citácie skopírované doslovne zo zdrojového záznamu metódy. Nevyplýva z nich žiadne overenie na úrovni tvrdenia.
- Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. · DOI 10.1038/nrg3000
- Pidsley, R., Zotenko, E., Peters, T. J., Lawrence, M. G., Risbridger, G. P., Molloy, P., Van Djik, S., Muhlhausler, B., Stirzaker, C., & Clark, S. J. (2016). Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biology, 17(1), 208. · DOI 10.1186/s13059-016-1066-1
Spracované tvrdenia
Tvrdenia uložené v registri dôkazov, každé s vlastným hodnotením.
Tento pohľad nevymýšľa hodnotenie tvrdenia, ak register žiadne nemá.
Súvisiace metódy
Vygenerované z grafu metód a zobrazené ako vzťahy navrhnuté strojom – nevyplýva z nich žiadne tvrdenie o dôkaze.